Provided by Tiger Fintech (Singapore) Pte. Ltd.

NCI

27.600
+1.1504.35%
Volume:27.31M
Turnover:745.62M
Market Cap:86.10B
PE:9.22
High:27.750
Open:26.900
Low:26.800
Close:26.450
Loading ...

BlackRock's Long Position in H-Shares of New China Life Insurance Decreases to 4.62% on Oct 30 From 5.15% - HKEX

THOMSON REUTERS
·
04 Nov 2024

BRIEF-New China Life Insurance Posts Qtrly Net Profit Attributable RMB9,597 Million

Reuters
·
30 Oct 2024

New China Life Insurance - Qtrly Net Profit Attributable RMB9,597 Mln

THOMSON REUTERS
·
30 Oct 2024

NCI and Liwa Trading Enterprises LLC Launch Joint Venture: Target to Debut E-Shop by Year-End

GlobeNewswire
·
28 Oct 2024

Purple Biotech Presents New Data for its Novel Tri-Specific T Cell and NK Cell Engagers Antibody Platform, CAPTN-3, at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

GlobeNewswire
·
25 Oct 2024

Prelude Therapeutics Presents New Data from SMARCA Degrader Portfolio at the 36th EORTC-NCI-AACR Symposium

GlobeNewswire
·
24 Oct 2024

Avacta Reports Pipeline Advances with Two Novel Programs at the EORTC-NCI-AACR Molecular Targets Symposium in Barcelona

GlobeNewswire
·
24 Oct 2024

Cyclacel Pharmaceuticals Reports New Clinical Data from Ongoing, Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium

GlobeNewswire
·
23 Oct 2024

Kronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven Tumors

GlobeNewswire
·
23 Oct 2024

Aprea Therapeutics Presents Preliminary Findings on Oral WEE1 Inhibitor APR-1051 at EORTC-NCI-AACR International Conference on Molecular Targets and Therapeutics

GlobeNewswire
·
23 Oct 2024

Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2024 AACR-NCI-EORTC Symposium on Molecular Targets and Cancer Therapeutics

GlobeNewswire
·
23 Oct 2024

Monte Rosa Therapeutics Presents Preclinical Data at the 36th EORTC-NCI-AACR Symposium on the Potential of its Cyclin E1-directed Molecular Glue Degraders for the Treatment of CCNE1-Amplified Solid Tumors

GlobeNewswire
·
23 Oct 2024

Neo-Concept International Group Holdings Limited (NASDAQ:NCI) Stock Rockets 99% As Investors Are Less Pessimistic Than Expected

Simply Wall St.
·
22 Oct 2024

New China Life Logs 146 Billion Yuan in January-September Premium Income

MT Newswires Live
·
17 Oct 2024

Stock Track | NCI Shares Soar 6% on Strong Premium Income Growth

Stock Track
·
17 Oct 2024

BRIEF-New China Life Insurance Jan-Sept Accumulated Gross Premium Income RMB145,643.70 Mln

Reuters
·
17 Oct 2024